Ovarian and uterine development and hormonal feedback mechanism in a 46 XX patient with CYP19A1 deficiency under low dose estrogen replacement

Gynecological Endocrinology

Volumn 31, Issue 5, 2015, Pages 349-354

  Burckhardt, Marie Anne ^a   Obmann, Verena ^b   Wolf, Rainer ^b   Janner, Marco ^a   Flück, Christa E ^a   Mullis, Primus E ^a  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Aromatase; Estradiol treatment; Gonadotrophic axis; Inhibin B; Ovarian and uterine development; Ovarian cysts

Indexed keywords

AROMATASE; DYDROGESTERONE; ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; CYP19A1 PROTEIN, HUMAN; ESTROGEN; INHIBIN;

ADD ON THERAPY; ADOLESCENT; AROMATASE DEFICIENCY; ARTICLE; CASE REPORT; CHILD; CHILDHOOD; CORRELATION ANALYSIS; CYP19A1 GENE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFECT; ESTROGEN THERAPY; FEEDBACK SYSTEM; FEMALE; FOLLOW UP; GENE; HETEROZYGOTE; HORMONE METABOLISM; HUMAN; LOW DRUG DOSE; OVARY CYST; OVARY DEVELOPMENT; POINT MUTATION; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; ULTRASOUND; UTERUS; 46, XX DISORDERS OF SEX DEVELOPMENT; DEFICIENCY; GENETICS; GROWTH, DEVELOPMENT AND AGING; GYNECOMASTIA; INFANT; INFERTILITY, MALE; METABOLISM; METABOLISM, INBORN ERRORS; ORAL DRUG ADMINISTRATION; OVARY; PROCEDURES;

46, XX DISORDERS OF SEX DEVELOPMENT; ADMINISTRATION, ORAL; ADOLESCENT; AROMATASE; CHILD; CHILD, PRESCHOOL; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GYNECOMASTIA; HUMANS; INFANT; INFERTILITY, MALE; INHIBINS; LUTEINIZING HORMONE; METABOLISM, INBORN ERRORS; OVARY; RETROSPECTIVE STUDIES; UTERUS;

EID: 84931435271     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2014.995619     Document Type: Article

References (32)

1. Belgorosky A, Guercio G, Pepe C, et al. Genetic and clinical spectrum of aromatase deficiency in infancy, childhood and adolescence. Horm Res 2009;72:321-30.
2. Simpson ER, Clyne C, Rubin G, et al. Aromatase-a brief overview. Annu Rev Physiol 2002;64:93-127.
3. Mullis PE, Yoshimura N, Kuhlmann B, et al. Aromatase deficiency in a female who is compound heterozygote for two new point mutations in the p450arom gene: impact of estrogens on hypergonadotropic hypogonadism, multicystic ovaries, and bone densitometry in childhood. J Clin Endocrinol Metab 1997;82:1739-45.
4. Janner M, Fluck CE, Mullis PE. Impact of estrogen replacement throughout childhood on growth, pituitary-gonadal axis and bone in a 46,xx patient with cyp19a1 deficiency. Horm Res Paediatr 2012; 78:261-8.
5. Belgorosky A, Pepe C, Marino R, et al. Hypothalamic-pituitaryovarian axis during infancy, early and late prepuberty in an aromatase-deficient girl who is a compound heterocygote for two new point mutations of the cyp19 gene. J Clin Endocrinol Metab 2003;88:5127-31.
6. Bulun SE. Physiology and pathology of the female reproductive axis. In: Shlomo M, Polonsky KS, Larsen Reed P, Kronenberg HM, eds. Williams textbook of endocrinology. Philadelphia: Saunders Elsevier; 2011:581-604.
7. Groome NP, Illingworth PJ, O'Brien M, et al. Measurement of dimeric inhibin b throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-5.
8. Guercio G, Di Palma MI, Pepe C, et al. Metformin, estrogen replacement therapy and gonadotropin inhibition fail to improve insulin sensitivity in a girl with aromatase deficiency. Horm Res 2009;72:370-6.
9. Verma N, Jain V, Birla S, et al. Growth and hormonal profile from birth to adolescence of a girl with aromatase deficiency. J Pediatr Endocrinol Metab 2012;25:1185-90.
10. Holm K, Laursen EM, Brocks V, Muller J. Pubertal maturation of the internal genitalia: an ultrasound evaluation of 166 healthy girls. Ultrasound Obstet Gynecol 1995;6:175-81.
11. Herter LD, Golendziner E, Flores JA, et al. Ovarian and uterine sonography in healthy girls between 1 and 13 years old: correlation of findings with age and pubertal status. AJR Am J Roentgenol 2002;178:1531-6.
12. Crofton PM, Evans AE, Groome NP, et al. Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, fsh and oestradiol. Clin Endocrinol (Oxf) 2002;56:223-30.
13. Sehested A, Juul AA, Andersson AM, et al. Serum inhibin a and inhibin b in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab 2000;85:1634-40.
14. Salardi S, Orsini LF, Cacciari E, et al. Pelvic ultrasonography in premenarcheal girls: relation to puberty and sex hormone concentrations. Arch Dis Child 1985;60:120-5.
15. Klein KO, Baron J, Colli MJ, et al. Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. J Clin Invest 1994;94:2475-80.
16. Kalra B, Kumar A, Patel K, et al. Development of a second generation inhibin b elisa. J Immunol Methods 2010;362:22-31.
17. Badouraki M, Christoforidis A, Economou I, et al. Sonographic assessment of uterine and ovarian development in normal girls aged 1 to 12 years. J Clin Ultrasound 2008;36:539-44.
18. Shozu M, Akasofu K, Harada T, Kubota Y. A new cause of female pseudohermaphroditism: placental aromatase deficiency. J Clin Endocrinol Metab 1991;72:560-6.
19. Ito Y, Fisher CR, Conte FA, et al. Molecular basis of aromatase deficiency in an adult female with sexual infantilism and polycystic ovaries. Proc Natl Acad Sci USA 1993;90:11673-7.
20. Morishima A, Grumbach MM, Simpson ER, et al. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-98.
21. Portrait-Doyen S, Forest MG, Nicolino M, et al. Female pseudohermaphroditism resulting from aromatase (p450arom) deficiency associated with a novel mutation (r457x) in the cyp19 gene. Horm Res 1996;46(suppl 2), 14.
22. Ludwig M, Beck A, Wickert L, et al. Female pseudohermaphroditism associated with a novel homozygous g-to-a (v370-to-m) substitution in the p-450 aromatase gene. J Pediatr Endocrinol Metab 1998;11:657-64.
23. Lin L, Ercan O, Raza J, et al. Variable phenotypes associated with aromatase (cyp19) insufficiency in humans. J Clin Endocrinol Metab 2007;92:982-90.
24. Richter-Unruh A, Schmidt M, Verhoef-Post M. Aromatase deficiency: delayed puberty in a german girl is due to 2 new mutations of the cyp19 gen. 90th Annl Meet Endocrine Soc; San Francisco; 2008; Abstract P2-590.
25. Hauri-Hohl A, Meyer-Boni M, Lang-Muritano M, et al. Aromatase deficiency owing to a functional variant in the placenta promoter and a novel missense mutation in the cyp19a1 gene. Clin Endocrinol (Oxf) 2011;75:39-43.
26. Ludwikowski B, Heger S, Datz N, et al. Aromatase deficiency: rare cause of virilization. Eur J Pediatr Surg 2013;23:418-22.
27. Gagliardi L, Scott HS, Feng J, Torpy DJ. A case of aromatase deficiency due to a novel cyp19a1 mutation. BMC Endocr Disord 2014;14:16.
28. Bouchoucha N, Samara-Boustani D, Pandey AV, et al. Characterization of a novel cyp19a1 (aromatase) r192h mutation causing virilization of a 46,xx newborn, undervirilization of the 46,xy brother, but no virilization of the mother during pregnancies. Mol Cell Endocrinol 2014;390:8-17.
29. Sudeep K, Abraham J, Seshadri L, Seshadri MS. Aromatase deficiency: an unusual cause for primary amenorrhea with virilization. J Assoc Phys India 2013;61:340-3.
30. Cohen HL, Eisenberg P, Mandel F, Haller JO. Ovarian cysts are common in premenarchal girls: a sonographic study of 101 children 2-12 years old. AJR Am J Roentgenol 1992;159:89-91.
31. Plant TM. Hypothalamic control of the pituitary-gonadal axis in higher primates: key advances over the last two decades. J Neuroendocrinol 2008;20:719-26.
32. Taboada M, Santen R, Lima J, et al. Pharmacokinetics and pharmacodynamics of oral and transdermal 17beta estradiol in girls with turner syndrome. J Clin Endocrinol Metab 2011;96: 3502-10.